Advent International to Infuse ₹3,150 Crore of Primary Capital

Under the agreement, Advent International will invest ₹3,150 crore of primary capital in Yatharth Hospitals. Following completion of the transaction, Advent is expected to own a 24.9% stake in the company.

The transaction remains subject to customary closing conditions.

The investment gives Yatharth Hospitals substantial fresh capital that can support its expansion strategy while bringing Advent's international healthcare investment experience into the business.

The Tyagi family, which founded and promotes Yatharth Hospitals, will remain the company's largest shareholder after the transaction and will continue to participate in its long-term strategic direction.

Yatharth Hospitals Plans Its Next Phase of Expansion

Founded in 2008, Yatharth Hospitals has developed a sizeable healthcare network focused primarily on North India.

The company currently operates nine multi-speciality hospitals with approximately 2,800 operational beds. Its overall announced capacity is around 3,250 beds as it continues to expand through both organic development and acquisitions.

Its network extends across important healthcare markets including the National Capital Region and Madhya Pradesh, with a growing presence in additional cities.

The fresh capital from Advent could provide Yatharth with greater financial flexibility to expand capacity, strengthen clinical capabilities and pursue further growth opportunities.

Advent Brings Extensive Healthcare Investment Experience

Healthcare is an established investment area for Advent International. The private equity firm has invested in more than 55 healthcare businesses across 17 countries over more than three decades.

Its healthcare investments in India have included businesses such as Apollo 24/7, Cohance, Felix Pharma, Bharat Serums and Vaccines and CARE Hospitals.

Advent manages more than $109 billion in assets and has completed hundreds of investments globally across multiple industries.

The Yatharth transaction adds another hospital platform to its broader exposure to India's healthcare ecosystem.

Private Equity Interest in Indian Healthcare Continues to Grow

The transaction comes amid sustained private equity and strategic investment activity across India's healthcare industry.

Hospital networks have attracted investor attention as healthcare access expands, demand for specialised treatment grows and organised providers increase their presence beyond India's largest metropolitan markets.

Consolidation has also become an important feature of the sector as larger hospital operators and financial investors seek scalable regional and national healthcare platforms.

Several major international investment firms have participated in significant Indian healthcare transactions in recent years, highlighting the growing institutional interest in hospitals, diagnostics, fertility services, pharmaceuticals and digital healthcare.

Yatharth's Regional Network Offers Expansion Potential

Yatharth's existing presence across North India provides Advent with exposure to a hospital network operating across several large and rapidly developing urban markets.

The company has expanded its footprint through a combination of new capacity and acquisitions, creating a platform that can potentially support additional hospitals and specialised healthcare services.

Its planned increase from roughly 2,800 operational beds toward an announced capacity of approximately 3,250 beds illustrates the scale of its current expansion programme.

Access to fresh primary capital could help accelerate that strategy without transferring control away from the promoter family.

Market Reacts to the Advent-Yatharth Transaction

Yatharth Hospitals shares moved sharply higher following the announcement of the investment, reaching record levels during trading as investors assessed the implications of the capital infusion and Advent's entry as a major minority shareholder.

The market reaction also reflected expectations that the partnership could strengthen Yatharth's ability to pursue its longer-term expansion plans.

For Advent, the transaction provides a substantial minority position in a listed Indian hospital operator while allowing the existing promoters to retain their leadership role.

What the Deal Means for India's Hospital Investment Landscape

The ₹3,150 crore investment illustrates how India's hospital industry is increasingly becoming an important destination for large global pools of private capital.

Unlike a conventional secondary stake purchase in which money primarily changes hands between shareholders, the Yatharth transaction involves primary capital being injected into the company.

That distinction means the investment can directly strengthen Yatharth's financial resources for future growth.

As organised healthcare providers expand into new cities and increase bed capacity, large-scale capital requirements are likely to remain an important part of the sector's development.

Conclusion

Advent International's proposed ₹3,150 crore investment for a 24.9% stake in Yatharth Hospitals represents a significant transaction for both the company and India's hospital investment market.

The deal gives Yatharth substantial primary capital while allowing the Tyagi family to remain its largest shareholder. For Advent, it expands the firm's already significant exposure to India's healthcare industry.

With Yatharth operating nine hospitals and planning further capacity expansion, the partnership will now be closely watched for how the new capital is deployed across hospital expansion, acquisitions and clinical capabilities.